Trends in the pharmacology of opioids: Implications for the pharmacotherapy of pain

European Journal of Pain

Volumn 5, Issue SUPPL. A, 2001, Pages 49-57

  Mather, Laurence E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Drug delivery systems; Metabolism; Opioids: Chemistry; Pharmacokinetics; Receptors

Indexed keywords

DRUG METABOLITE; FENTANYL; MORPHINE; NORPETHIDINE; OPIATE DERIVATIVE; PETHIDINE;

CONFERENCE PAPER; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG METABOLISM; DRUG RECEPTOR BINDING; HUMAN; NERVE CELL PLASTICITY; NEUROMODULATION; NOCICEPTION; PAIN; PATHOPHYSIOLOGY; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL;

EID: 0035693747     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1053/eujp.2000.0214     Document Type: Conference Paper

References (57)

1. Multiple intramuscular injections: A major source of variability in analgesia response to meperidine
2. Relationship between blood meperidine concentrations and analgesic response
3. Pethidine clearance during continuous intravenous infusion in post-operative patients
4. Synthetic analgesics: Stereochemical considerations
5. Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients
6. Opioids and non-opioid enantiomers selectively attenuate N-methyl-D-aspartate neurotoxicity on cortical neurons
7. Intrathecal and epidural administration of opiates
8. Pharmacokinetics of opioids in renal dysfunction
9. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia
10. Pharmacokinetics and phannacodynamics of remifentanil in volunteer subjects with severe liver disease
11. Remifentanil versus alfentanil: Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers
12. Clinical pharmacokinetics applied to patients with intractable pain: Studies with pethidine
13. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine
14. Postoperative pain control with methadone: Influence of supplementary methadone doses and blood concentration-response relationships
15. Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain
16. Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain
17. Adverse cardiac manifestations following dextropropoxyphene overdose: Can naloxone be helpful?
18. Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmaco-dynamics
19. Patient-controlled analgesia: Pharmacokinetic and therapeutic considerations
20. Identification of two related pentapeptides from the brain with potent opiate agonist activity
21. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthesia
22. Narcotic analgesics
23. Opioid analgesics and Antagonists
24. The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats
25. Multimodal approach to control postoperative pathophysiology and rehabilitation
26. The effects of morphine- and nalorphine like drugs in the nondependent and morphine-dependent chronic spinal dog
27. Novel methods of analgesic drug delivery
28. The minimum effective analgetic blood concentration of pethidine in patients with intractable pain
29. The incidence of postoperative pain in children
30. Systemic availability of orally administered meperidine
31. Pharmacokinetics of opioids in the context of patient controlled analgesia
32. Pethidine revisited: Plasma concentrations and effects after intramuscular injection
33. A sheep preparation for studying interactions between blood flow and drug disposition. V: Pethidine disposition
34. Pulmonary administration of aerosolised fentanyl: Pharmacokinetic evaluation of systemic delivery
35. Comparative disposition of morphine-3-glucuronide during separate intravenous infusions of morphine and morphine-3-glucuronide in sheep: Importance of the kidney
36. The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine
37. Influence of renal failure of the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep
38. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development
39. Opiate receptor: Demonstration in nervous tissue
40. Behavioural effects of norpethidine, a metabolite of pethidine, in rats
41. Opioid analgesics and Antagonists
42. A pharmacokinetic approach to pain control: Continuous infusion of pethidine
43. Peripheral mechanisms of opioid analgesia
44. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex
45. The cerebral pharmacokinetics of meperidine and alfentanil in conscious sheep
46. cDNA cloning of an orphan opiate receptor gene family member and its splice variant
47. Morphine pharmacokinetics after pulmonary administration from a novel aerosol inhalation delivery system
48. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors
49. Patient-controlled analgesia (PCA) for postoperative pain relief: What have we learnt and where do we go from here?
50. The effect of duration of dose delivery on incidence of nausea and vomiting in total abdominal hysterectomy patients using patient-controlled analgesia (PCA)
51. The minimum effective concentration (MEC) of opioids-a revisitation with PCA fentanyl
52. A comparison of morphine, pethidine and fentanyl in the post-surgical patient-controlled analgesia environment
53. Intra subject variability in patient-controlled analgesia (PCA): Is the patient equally satisfied with morphine, pethidine and fentanyl?
54. Preemptive analgesia-treating post-operative pain by preventing the establishment of central sensitization
55. Hydromorphone-3-glucuronide: A more potent neuro-excitant than its structural analogue, morphine-3-glucuronide
56. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain